ELND005

· OPKO Health, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ELND005, covering 2012-03-29 to 2016-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease [Phase 2]